HANGZHOU TIGERMED CONSULTING CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.2 USD | -4.55% |
|
-.--% | -.--% |
| Jul. 03 | Tranche Update on Hangzhou Tigermed Consulting Co., Ltd's Equity Buyback Plan announced on May 24, 2024. | CI |
| Jun. 18 | Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 45.01B | - | |||||
| 40.96B | ||||||
| 38.62B | ||||||
| 32.6B | - | |||||
| 27.49B |
